Introduction
Werner syndrome (WS) is a rare autosomal recessive genetic disorder causing premature aging including a short stature, juvenile cataracts, atrophy of the skin, graying and loss of hair, diabetes, arteriosclerosis, osteoporosis, accompanied by rare cancers (Epstein et al., 1966) . In vitro studies of ®broblast growth characteristics also suggest that WS may be related to normal aging: the life span of WS ®broblasts as expressed by population doubling levels is much shorter than that of normal ®broblasts (Salk et al., 1985; Faragher et al., 1993) . The gene, WRN, responsible for WS encodes a protein with 1432 amino acids (a.a.) homologous to E. coli RecQ DNA helicase (Yu et al., 1996) . Although the recombinant human WRN protein (hWRNp) shows an ATP-dependent 3'-to-5' DNA unwinding activity (Gray et al., 1997; Suzuki et al., 1997) and an exonuclease activity in the N-terminal region (Huang et al., 1998; Suzuki et al., 1999) , its biological function in the replicative senescence of cells remains to be clari®ed.
The nuclear localization of hWRNp is driven by a nuclear localization signal (NLS), NKRRCF, at the Cterminal region (residues 1370 ± 1375 a.a.), and the absence of an NLS in truncated hWRNp in WS patients cells is ascribed to the primary pathogenesis that explains a set of similar clinical phenotypes of WS patients, irrespective of dierent mutation types (Matsumoto et al., 1997 (Matsumoto et al., , 1998 . Recent studies by immunocytochemistry using speci®c antibodies showed that endogenous hWRNp exists in both the nucleoplasm and the nucleolus in growing cells Marciniak et al., 1998; Kitao et al., 1999; Shiratori et al., 1999) . In resting cells, however, hWRNp disappears from the nucleolus in spite of no detectable change in the total amount of hWRNp in the nucleus . These ®ndings suggest a possible function of hWRNp in transcriptionally active nucleoli and indicate that a nucleoplasm-nucleolus tracking of hWRNp may exist although the mechanism underlying the tracking remains to be resolved. By contrast, the murine homolog of WRNp (mWRNp) is found only in the nucleoplasm Marciniak et al., 1998; Shiratori et al., 1999) . More interestingly, WRN-de®cient mice are born at the expected Mendelian frequency and show no overt histological signs of accelerated senescence (Lebel and Leder, 1998; Lombard et al., 2000) .
In this study, the molecular basis for this bilocalization of hWRNp in the nucleolus and nucleoplasm and for the inability of mWRNp to be transported to the nucleolus remaining in the nucleoplasm was investigated. Here we identi®ed a region containing nucleolar localization signal (NoLS) in hWRNp. We found that the sequence dierences in this region between mWRNp and hWRNp, and that NoLS in hWRNp does not work in the nucleolar targeting pathway in mouse cells. staining with a monoclonal antibody speci®c for the Cterminal regions of hWRNp showed various patterns of subnuclear distribution of endogenous hWRNp in interphase HeLa cells (Figure 1 ). These patterns are brie¯y classi®ed as three typical patterns: distributed almost in the nucleoplasm and scarcely in the nucleoli (Figure 1a) , distributed in both the nucleoplasm and nucleoli (Figure 1b) , accumulated exclusively in the nucleoli (Figure 1c ). During metaphase, hWRNp was released from the nucleoplasm to the cytoplasm . Gray et al. (1998) demonstrated that hWRNp was released from the nucleolus to the nucleoplasm when the cells were serum-starved or exposed to genotoxic agents, 4-nitroquinoline-1-oxide. We could also recon®rm the fact that a time-dependent and rapid increase in population of cells showing nucleolar localization of hWRNp was observed upon transcription activation by serum re-addition (data not shown). By contrast, cells characterized with the nucleoplasmic distribution of hWRNp without its nucleolar localization frequently had a relatively large nucleus among asynchronously cultured cells as shown in Figure 1a , suggesting they might progress through to the G 2 phase. Reduced transcriptional activity during the G 0 and the late G 2 phases may induce the translocation of hWRNp from the nucleoli to the nucleoplasm.
Like endogenous hWRNp, the EGFP fused with wild-type hWRNp was found exclusively in the nucleus of transfected HeLa cells (Figure 2a) , showing the three patterns of subnuclear distribution (Figure 2a) . When transfected cells were double-stained with anti-GFP antibody and anti-hWRNp antibody, exogenously over-expressed hWRNp showed a distribution pattern similar to that of the immunoreactivity of endogenous hWRNp detected in untransfected cells surrounding them (Figure 2b ). This ®nding supports the view that the transgene-expressed fusion protein can be used to assess a subnuclear distribution of endogenous hWRNp. In the transfected HeLa cells, EGFPhWRNp was distributed in both the nucleoli and the nucleoplasm showing a relatively higher concentration in the nucleoli than in the nucleoplasm.
To understand the molecular basis for this trac of hWRNp between the nucleolus and the nucleoplasm, we analysed potential NoLS in hWRNp. From the amino acid sequence motifs of known NoLS (GarciaBustos et al., 1991), we predicted the existence of an NoLS in the C-terminal region of hWRNp, which contains the basic amino acid motif (residues 1403 ± 1406 a.a.). The EGFP fused with a mutant hWRNp lacking the C-terminal 30 a.a. region (EGFP-hWRNp D1403 ± 1432) existed only in the nucleoplasm ( Figure  2c ), while a hWRNp-speci®c antibody stained the (Figure 2d ). The impaired nucleolar localization of the EGFP-hWRNp D1403 ± 1432 suggests that the Cterminal 30 a.a. region of hWRNp may contain an NoLS. To narrow further the site of the putative NoLS, we transfected HeLa cells with a series of expression plasmids that encode the EGFP fused with the C-terminal region (residues 1370 ± 1432 a.a.) of hWRNp. The resulting EGFP-fused proteins containing both the NLS and the putative NoLS of hWRNp should be exclusively accumulated in the nucleoli. Figure 3a ± c show representative images of subnuclear distribution of the fusion proteins. We found that the fusion proteins lacking the C-terminal residues 1405 ± 1432 a.a. of hWRNp can localize exclusively in the nucleoli, suggesting a putative NoLS does not exist in the C-terminal 28 a.a. residues (Figure 3a) . However, the fusion proteins lacking the C-terminal residues 1404 ± 1432 a.a. of hWRNp could migrate into nucleoli with a simultaneous distribution of their¯uorescence in the nucleoplasm (Figure 3b ). All fusion proteins lacking C-terminal fragments of hWRNp longer than 30 a.a. completely failed to migrate into the nucleoli and remained exclusively in the nucleoplasm ( Figure  3c ). , were unlikely to be essential for the nucleolar localization of hWRNp. Phosphorylation of amino acid residues around an NLS increases the nuclear import of SV40 large T-antigen through an increase in anity of NLS recognition by a nuclear transporter, importin Xiao et al., 1997) . A possibility might exist that directions of nucleolus-nucleoplasm tracking of . However, each one-amino acid substitution of these amino acid residues with Val, Ala and Ala, respectively, did not in¯uence the nucleolar localization of EGFP-fused proteins containing both the NLS and the NoLS of hWRNp (data not shown). Other unknown mechanisms might exist to control the directions of nucleolus-nucleoplasm tracking of hWRNp.
Mouse WRN cDNA encodes a protein of 1401 a.a. that shows an extremely high homology (95% homology) to hWRNp in the helicase domain conserved in the helicase superfamily, and an overall homology of 69% in the remaining region . The mWRNp contains an SRKRRF sequence similar to the NLS of hWRNp at an almost identical region (amino acid residues 1335 ± 1340 a.a.) to hWRNp (Figure 4a ). Indeed, our previous studies showed that a deletion mutant of mWRNp that lacked this putative NLS failed to transport the fused EGFP to the nuclei in the mouse cells, while the whole mWRNp and the C-terminal polypeptide of mWRNp containing the putative NLS could transport the fused EGFP to the nuclei (Matsumoto et al., 1998) . In contrast to the conservation of sequence homology of the NLS that was proved by these studies, Ser 1367 in mWRNp, corresponding to Arg 1403 in the putative NoLS of hWRNp, is not a basic amino acid species (Figure 4a) , suggesting a potential defect in nucleolar localization of mWRNp. The fusion protein containing N-terminal EGFP and the wild type of mWRNp transported to the nuclei failed to migrate to the nucleolus and remained in the nucleoplasm, like endogenous mWRNp (Marciniak et al., 1998; Shiratori et al., 1999) , in any mouse cultured cell line, such as embryonic ®broblasts (MEFs) (Figure 4b ), B16F10 mouse melanoma cells (Figure 4c) , and colon 26 mouse carcinoma cells (data not shown) investigated in this study. When the fusion protein containing N-terminal EGFP and the wild type of mWRNp was expressed in HeLa cells, it failed to be transported to the nucleolus, as observed in the mouse cells (Figure 4d ), in spite of the nucleolar accumulation of endogenous hWRNp in cells surrounding the gene-transfected cells (Figure 4e ). In contrast, nucleolar migration of a fusion protein containing EGFP and mWRNp occurred in HeLa cells when Ser 1367 was substituted with Arg to imitate the potential NoLS of hWRNp (Figure 4f ). These results ensure that mWRNp has lost or hWRNp has acquired an ability of nucleolar migration during evolution. However, in MEFs, nucleolar migration of the mWRNp mutant with Arg 1367 (mWRNp/S1367R) did not occur and mWRNp/S1367R remained in the nucleoplasm (Figure 5a ). The same results were obtained when mWRNp/S1367R was expressed in the other mouse cell lines, such as B16F10 and colon 26 (data not shown). Similarly, nucleolar migration of EGFP-hWRNp did not occur in MEFs (Figure 5b ). Previous work with transgenic mice expressing human WRN also showed that hWRNp expressed in primary tail ®broblasts was localized to the nucleoplasm (Wang et al., 2000) . These ®ndings suggest an absence of a certain nucleolar targeting pathway in mouse cells for WRNp, which recognizes the NoLS sequence of WRNp.
Our results show that the NoLS in the C-terminus of hWRNp is necessary to direct the nucleolar localization. Despite the presence of the NoLS, nucleolar localization of hWRNp is not always observed in several cell lines as we reported previously (Kitao et al., 1999; . How hWRNp shows this bi-directional tracking has not been well understood, but the present study demonstrates that transcriptional state of cells appears to permit the nucleolar tracs of hWRNp. hWRNp is accumulated in the nucleoli when rRNA transcription is stimulated. By contrast, cells lacking transcriptional activity when introduced into the G 0 phase or during progression in the late G 2 phase show the nucleoplasmic distribution of hWRNp released from the nucleoli. Moreover, during the M phase, hWRNp is released from the condensed chromatin to the cytoplasm . These results suggest that hWRNp might be involved in a certain event associated with rRNA transcription, such as repair of DNA damages in transcriptionally active chromatins (Chiu et al., 1982) , transcription-stimulated mitotic recombination of the rDNA region (Stewart and Roeder, 1989) , and rRNA transcription itself.
The inability of mWRNp to migrate to the nucleolus in mouse cells may be due to the lack of NoLS. On the other hand, the inability of hWRNp to migrate to the nucleolus in mouse cells implies that the nucleolar tracking system may be dierent between human and mouse cells. Both hWRNp and mWRNp have similar enzyme characteristics of ATP-dependent DNA-unwinding activity (Gray et al., 1997; Shiratori et al., unpublished observation; Suzuki et al., 1997) and exonuclease activity (Huang et al., 1998 (Huang et al., , 2000 Suzuki et al., 1999) . Therefore mice carrying defective WRN genes must show certain phenotypes, such as accelerated aging or other abnormalities, if mWRNp plays a critical role in nucleoplasmic area. However, mWRN 7/7 mutant mice are healthy and fertile, showing no signs of premature organismic aging or increased rates of tumor formation, and cells from these animals do not show elevated susceptibility to genotoxins (Lombard et al., 2000) . From the point of view that mWRNp may have no primary biological function in the nucleoplasm despite the fact that it can mimic enzymatic activities of hWRNp, it might be unlikely that defect in biological function of hWRNp in the nucleoplasm results in the premature aging in humans. Thus, it is possible that defective nucleolar function of hWRNp may be related to the accelerated aging and that there may be some factor compensating mWRNp in a certain event associated with rRNA transcription. These possibilities will be evidenced by typing the novel mutation of hWRNp lacking the Cterminal 30 a.a. residues and by functional characterization of hWRNp in the nucleolus. In this study, we show species-based dierences in both sequences of the amino acid residues corresponding to NoLS and nucleolar transportation system of the respective WRNp. The fact that gene-disrupted mice with a defective mWRNp show no overt histological signs of accelerated aging as found with WS patients (Lebel and Leder, 1998; Lombard et al., 2000) prompts us to inquire if the apparent dierence in subnuclear localization of WRNp is relevant to the dierence in the aging pathway between human and mouse cells. Functional characterization of hWRNp in nucleoli may advance our understanding of the aging mechanism of humans.
Materials and methods
Using¯uorescence microscopy, we analysed the localization of a series of hWRNp and mWRNp mutants in cultured cells by expressing them in N-terminally-tagged forms with an enhanced green¯uorescent protein (EGFP). cDNA clones containing the coding region of native or truncated hWRN genes were prepared by PCR using Pfu DNA polymerase (Stratagene, La Jolla, CA, USA). A cDNA clone encoding a one base-substituted mWRNp mutant (mWRNp/S1367R) was prepared by PCR using Pfu DNA polymerase with DNA primers designed for substitution of Ser 1367 with Arg. Each cDNA clone was placed downstream of the EGFP sequence in the pEGFP-C3 DNA (Clontech, Palo Alto, CA, USA) according to the manufacturer's instructions. Cells were seeded onto a Lab-Tek chamber slide (Nalge Nunc International, Napervill, IL, USA), were cultured overnight with 10% fetal calf serum in Dulbecco's modi®ed Eagle's medium at 378C and then were transfected with 6 mg of the expression plasmid DNA mixed with 4 ml of Fugene TM 6 transfection reagent (Roche Diagnostics, Mannheim, Germany). Twenty hours after transfection at 378C, the cells were ®xed with 10% formalin in PBS, followed by immunostaining with rabbit anti-GFP polyclonal antibody (Clontech, Palo Alto, CA, USA). Exogenously expressed and endogenous hWRNp were stained with mouse anti-hWRNp monoclonal antibody, 8H3 and endogenous nucleophosmin/B23 was stained with goat anti-B23 polyclonal antibody, sc-6013 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Alexa Fluor TM 488 and Alexa Fluor TM 594 (Molecular Probes, Eugene, OR, USA) were used as second antibodies. Fluorescent images were visualized using a Bionanoscope (Nikon Engineering) or a Fluoview (Olympus).
respectively. Overlaid images of green and red¯uorescences are also shown. Blue¯uorescence shows nuclei counterstained with DAPI. The wild-type of mWRNp (e) and mWRNp of which Ser 1367 (a green letter in a) was substituted with Arg (mWRNp/ S1367R) (f) were expressed in HeLa cells as fusion proteins with EGFP. Black or white scale bars in DIC or DAPI images represent 20 mm length 
